Advanced Cardiovascular Imaging Consortium (ACIC)
Coronary Artery Disease
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||Advanced Cardiovascular Imaging Consortium: A Collaborative Quality Improvement Project|
- Educate participating sites on appropriate use of CCTA [ Time Frame: 5 years ]To educate participating sites in the clinical uses of CCTA recommended by the ACC/ACR as well as other best-practices
- To monitor the CQI process of individual participating sites and the ACIC as a whole. [ Time Frame: 5 years ]
|Study Start Date:||July 2007|
|Study Completion Date:||April 2014|
|Primary Completion Date:||April 2014 (Final data collection date for primary outcome measure)|
All patients in whom a clinical CCTA was ordered by their physician at a participating site. Patient must have a prescription for CCTA ordered by their physician.
This study is a collaborative quality assurance initiative organized by Blue Cross Blue Shield of Michigan and Blue Cross Network (BCBSM/BCN) for initiation of insurance coverage of coronary artery CT scanning (CCTA), a relatively new procedure that can provide non-invasive coronary angiograms. While this procedure has promise in that it can rapidly diagnose patients with unknown chest pain and reduce the cost of medical care, there is substantial potential for abuse and excess cost and inappropriate care if not appropriately used.
The Consortium's objectives are to educate participating sites of the clinical uses of CCTA as well as other best-practice recommendations; to create a database (Registry) to develop evidence of the best-practice utilization of CCTA; to provide a feedback mechanism to the sites about the positive or negative evidence of best-practice utilization of CCTA; to develop strategies to improve the utilization of CCTA; to monitor the CQI process of the individual participating sites; to reduce cost and improve safety and efficiency in in the care of patients with acute chest pain, indeterminate stress tests results, and to assess coronary bypass graft patency.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00640068
Show 50 Study Locations
|Study Director:||Kavitha Chinnaiyan, MD||William Beaumont Hospitals|